| scholarly article | Q13442814 |
| P2093 | author name string | Reynolds HY | |
| Newball HH | |||
| Kazmierowski JA | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Induction of aryl hydrocarbon hydroxylase in human pulmonary alveolar macrophages by cigarette smoking | Q34508967 | ||
| Development of cellular and humoral immunity in the respiratory tract of rabbits to Pseudomonas lipopolysaccharide | Q34517474 | ||
| THE PARTICULATE HYDROLASES OF MACROPHAGES. II. BIOCHEMICAL AND MORPHOLOGICAL RESPONSE TO PARTICLE INGESTION | Q36266473 | ||
| The human secretory immunoglobulin system: immunohistoligical localization of gamma A, secretory "piece," and lactoferrin in normal human tissues | Q36269534 | ||
| Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b | Q36334997 | ||
| Human alveolar macrophages: comparison of phagocytic ability, glucose utilization, and ultrastructure in smokers and nonsmokers | Q37710705 | ||
| Primary immunodeficiencies. Report of a World Health Organization Committee | Q39866276 | ||
| New immunotype schema for Pseudomonas aeruginosa based on protective antigens | Q40287481 | ||
| The human alveolar macrophage: isolation, cultivation in vitro, and studies of morphologic and functional characteristics | Q40325101 | ||
| Pinocytosis by human alveolar macrophages. Comparison of smokers and nonsmokers | Q40368246 | ||
| Nosocomial pneumonia. A continuing major problem | Q43841021 | ||
| The ultrastructure of alveolar macrophages from human cigarette smokers and nonsmokers | Q45088250 | ||
| Alveolobronchiolar Transport Mechanisms | Q47961679 | ||
| Particle recognition by cultivated macrophages. | Q48012099 | ||
| Lack of Opsonization Potential of 11S Human Secretory A | Q48017754 | ||
| The J. Burns Amberson Lecture--in defense of the lung | Q48560706 | ||
| The isolation and biologic activities of purified secretory IgA and IgG anti-Salmonella typhimurium "O" antibodies from rabbit intestinal fluid and colostrum | Q50239175 | ||
| Characteristics of nonbacteremic Pseudomonas pneumonia. | Q53723072 | ||
| Immunoglobulins and other proteins in commercial preparations of gamma globulin. | Q53944868 | ||
| Structural units of canine serum and secretory immunoglobulin A. | Q54045317 | ||
| Pulmonary host defenses. II. Interaction of respiratory antibodies with Pseudomonas aeruginosa and alveolar macrophages. | Q54050975 | ||
| The Pulmonary Macrophage in Acute Leukemia | Q54061648 | ||
| The immunoglobulins derived from a VH-CH recombinant rabbit and its normal relatives. I. Measurements of heavy chain molecular weights and allotypes of colostral IgA. | Q54549839 | ||
| Receptors for immunoglobulin and complement on human alveolar macrophages | Q66923549 | ||
| Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with pseudomonas aeruginosa | Q67248378 | ||
| Pseudomonas pneumonia. A retrospective study of 36 cases | Q67251526 | ||
| Altered morphology and increased acid hydrolase content of pulmonary macrophages from cigarette smokers | Q68658984 | ||
| Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage | Q68787625 | ||
| Type-specific immunity in pseudomonas diseases | Q69371188 | ||
| Immunoglobulins in the bronchial washings of patients with chronic obstructive pulmonary disease | Q69371193 | ||
| Pseudomonas aeruginosa pneumonia in adults | Q69382452 | ||
| A structural study of human exocrine IgA globulin | Q70097068 | ||
| Immunoglobulin production in bronchial mucosa and bronchial lymph nodes, particularly in cystic fibrosis of the pancreas | Q70097077 | ||
| IMMUNOGLOBULINS IN NORMAL HUMAN TRACHEOBRONCHIAL WASHINGS: A QUALITATIVE AND QUANTITATIVE STUDY | Q76677590 | ||
| Determination of cell viability | Q78239579 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| antibody | Q79460 | ||
| macrophage | Q184204 | ||
| phagocytosis | Q184726 | ||
| P304 | page(s) | 376-385 | |
| P577 | publication date | 1975-08-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages | |
| P478 | volume | 56 |
| Q40684350 | Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs |
| Q36637394 | Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients |
| Q37019905 | Alveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization |
| Q64941015 | Antibacterial immunity of lower airways: local or localized? |
| Q39666286 | Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. I. K lymphocytes and monocytes are effective against meningococi in cooperation with human imune sera |
| Q40688162 | Antibody-dependent mononuclear cell-mediated antimeningococcal activity. Comparison of the effects of convalescent and postimmunization immunoglobulins G, M, and A. |
| Q40206035 | Appearance of specific antibody-bearing cells in human bronchial mucosa after local immunization with bacterial vaccine |
| Q69638986 | Complement-mediated enhancement of IgA-induced H2O2 release by human polymorphonuclear leucocytes |
| Q37004057 | Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay |
| Q37289786 | Cystic fibrosis. Infection and immunity to Pseudomonas. |
| Q73795121 | Cytological and immunological changes in bronchoalveolar lavage fluid and histological observation of lung lesions in pigs immunized with Mycoplasma hyopneumoniae inactivated vaccine prepared from broth culture supernate |
| Q44984317 | Deficient intracellular killing of bacteria by murine alveolar macrophages |
| Q36440794 | Differences in phagocytosis and killing by alveolar macrophages from humans, rabbits, rats, and hamsters |
| Q34420815 | Effect of alveolar macrophages on Toxoplasma gondii |
| Q36951075 | Effect of pyocyanine, a pigment of Pseudomonas aeruginosa, on production of reactive nitrogen intermediates by murine alveolar macrophages |
| Q35884669 | Effects of the combination of lipopolysaccharide-specific monoclonal antibodies and sparfloxacin against Pseudomonas aeruginosa pneumonia in neutropenic mice |
| Q40698555 | Host defenses against respiratory infection. |
| Q69841054 | Human bronchoalveolar macrophage heterogeneity demonstrated by histochemistry, surface markers and phagocytosis |
| Q36091567 | Hydrogen peroxide and superoxide release by alveolar macrophages from normal and BCG-vaccinated guinea-pigs after intravenous challenge with Mycobacterium tuberculosis |
| Q41829756 | IgA-dependent, monocyte-mediated, antibacterial activity |
| Q39627509 | Immunoglobulin G and its function in the human respiratory tract |
| Q70794732 | Immunoglobulin-containing cells and the origin of immunoglobulins in the respiratory tract of sheep |
| Q35089066 | In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide |
| Q36093118 | Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage |
| Q42578900 | Inhibition of Phagocytosis and Glucose Metabolism of Alveolar Macrophages during Pulmonary Tumour Growth |
| Q33910909 | Interaction of alveolar macrophages with Nocardia asteroides: immunological enhancement of phagocytosis, phagosome-lysosome fusion, and microbicidal activity |
| Q34096780 | Kinetics of phagocytosis of Staphylococcus aureus by alveolar and peritoneal macrophages |
| Q35959091 | Lung inflammation and fibrosis: an alveolar macrophage-centered perspective from the 1970s to 1980s |
| Q52448914 | Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection. |
| Q40181601 | Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients. |
| Q37208228 | Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients |
| Q34612136 | Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis |
| Q40426470 | Pseudomonas aeruginosa cytotoxin: periplasmic localization and inhibition of macrophages |
| Q45948772 | Pseudomonas aeruginosa immunotherapy. |
| Q40160354 | Pseudomonas aeruginosa pili as ligands for nonopsonic phagocytosis by fibronectin-stimulated macrophages |
| Q33901457 | Pseudomonas aeruginosa-induced lung and pleural injury in sheep. Differential protective effect of circulating versus alveolar immunoglobulin G antibody |
| Q46063609 | Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis |
| Q39794858 | Recent Advances in Human Cellular lmmunobiology |
| Q54538226 | Reduced resistance to Pseudomonas septicaemia in diabetic mice. |
| Q37002223 | Resistance of mucoid Pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in vitro |
| Q41065563 | Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa |
| Q35092429 | Stimulation by fibronectin of macrophage-mediated phagocytosis of Pseudomonas aeruginosa |
| Q36394850 | Subpopulations of human peripheral granulocyes and monocytes express receptors for IgA |
| Q41121765 | Surface morphology and function of human pulmonary alveolar macrophages from smokers and non-smokers |
| Q72787871 | Surface receptors for IgG and complement on equine alveolar macrophages |
| Q28321730 | The effect of tobacco smoke on the metabolism and function of rat alveolar macrophages |
| Q40476978 | The pathogenesis of ventilator-associated pneumonia: II. The lower respiratory tract |
| Q24307588 | The structure and function of human IgA |
| Q35808176 | Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia |
| Q40252878 | Tobacco smoke. Effects on pulmonary host defense |
| Q40912617 | Toxicity of Pseudomonas aeruginosa exotoxin A for human macrophages |
| Q72873787 | Treatment of murine macrophages with murine interferon-gamma and tumour necrosis factor-alpha enhances uptake and intracellular killing of Pseudomonas aeruginosa |
| Q37024316 | Use of monoclonal antibodies to protein F of Pseudomonas aeruginosa as opsonins for phagocytosis by macrophages |
| Q44313836 | Various approaches to clinically related research can yield helpful insight. A personal perspective |
Search more.